Page last updated: 2024-11-03

propranolol and Cancer of Endometrium

propranolol has been researched along with Cancer of Endometrium in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists."1.62Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies. ( Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Modzelewska, B1
Jóźwik, M2
Kleszczewski, T1
Sulkowski, S1

Other Studies

1 other study available for propranolol and Cancer of Endometrium

ArticleYear
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
    Gynecologic and obstetric investigation, 2021, Volume: 86, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolami

2021